Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 206 of 1,261
  1. US 11597916

    Nicotine degrading enzyme variants

    The Board of Regents of the University of Texas System · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  2. US 11597773

    CD6 antibody for treatment of T-cell mediated diseases or disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  3. US 11597749

    Peptide compositions and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  4. US 11597707

    CGAS antagonist compounds

    The Board of Regents of the University of Texas System · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  5. US 11597774

    Antibody variable domains and antibody constructs

    The Board of Regents of the University of Texas System · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  6. US 11596694

    Compositions and methods for predicting response to NaPi2b-targeted therapy

    Mersana Therapeutics, Inc. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  7. US 11596711

    Solubilization of antigen components for removal from tissues

    The Regents of the University of California · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  8. US 11598782

    Biomarkers and methods for detection of seizures and epilepsy

    Cognizance Biomarkers, LLC · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  9. US 11596660

    Methods of treating bladder cancer

    CG ONCOLOGY, INC. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  10. US 11596909

    System and method for droplet formation and manipulation using ferrofluids

    The Regents of the University of California · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  11. US 11596585

    Composition for the prevention of microbial growth

    Eikonic R&D Pty Ltd · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  12. US 11597727

    Inhibitors of integrin alpha 2 beta 1 and methods of use

    The Regents of the University of California · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  13. US 11597853

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Regents of the University of Minnesota · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  14. US 11596688

    Predicting outcome of treatment with an anti-α4β7 integrin antibody

    Takeda Pharmaceutical Company Limited · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  15. US 11596610

    Compositions in support of health and mental accuity

    HIGHER OPTIONS GLOBAL, INC. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  16. IL 300192

    Manufacturing of dimeric contrast agents

    BRACCO IMAGING SPA [IT] · Granted Mar 1, 2023 · Expires Feb 24, 2043

    granted
  17. US 11590113

    Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator

    Corcept Therapeutics Incorporated · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  18. US 11590156

    RNAi agents for hepatitis B virus infection

    Arrowhead Pharmaceuticals, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  19. US 11594135

    Methods of CD40 activation and immune checkpoint blockade

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  20. US 11591350

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  21. US 11591319

    Small molecule inducers of autophagy

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  22. US 11590092

    Skin probiotic

    The Regents of the University of California · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  23. US 11590221

    Dengue vaccine unit dose and administration thereof

    Takeda Vaccines, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  24. US 11594302

    High resolution allele identification

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.